The 3rd Conference on Next Generation Sequencing for Adventitious Virus Detection in Biologics for Humans and Animals will be held on September 27 – 28, 2022 at IBBR / University of Maryland, Rockville, U.S.A. This face-to-face meeting will focus on the recent expansion of scientific data and the current applications of next generation sequencing technologies for adventitious virus detection in biological products, including human and animal vaccines, as well as gene therapy, and therapeutic products.
Call For Abstracts is now OPEN!
Deadline extended to April 30, 2022
Scientific Committee:
Arifa S. Khan, U.S. Food and Drug Administration (FDA) – Co-Chair
Laurent Mallet, EDQM – Co-Chair
Pieter Neels, International Alliance for Biological Standardization (IABS)
Johannes Blümel, Paul-Ehrlich Institut (PEI)
Jean-Pol Cassart, GlaxoSmithKline
Mia Jakava-Viljanen, FIMEMA
Ivana Knezevic, World Health Organization (WHO)
Carine Logvinoff, Sanofi
Siemon Ng, Notch Therapeutics
Michael Wall, Health Canada
